A prospective study of treatment of carbapenem-resistant Enterobacteriaceae infections and risk factors associated with outcome.
about
Clinical and economic implications of urinary tract infections.Treatment of sepsis: What is the antibiotic choice in bacteremia due to carbapenem resistant Enterobacteriaceae?Pneumonia and Renal Replacement Therapy Are Risk Factors for Ceftazidime-Avibactam Treatment Failures and Resistance among Patients with Carbapenem-Resistant Enterobacteriaceae Infections.Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.Risk factors for carbapenem-resistant K. pneumoniae bloodstream infection and predictors of mortality in Chinese paediatric patients.Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a β-Lactamase Inhibitor, in Combination with Imipenem and Cilastatin in Healthy Participants
P2860
A prospective study of treatment of carbapenem-resistant Enterobacteriaceae infections and risk factors associated with outcome.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A prospective study of treatme ...... ctors associated with outcome.
@ast
A prospective study of treatme ...... ctors associated with outcome.
@en
type
label
A prospective study of treatme ...... ctors associated with outcome.
@ast
A prospective study of treatme ...... ctors associated with outcome.
@en
prefLabel
A prospective study of treatme ...... ctors associated with outcome.
@ast
A prospective study of treatme ...... ctors associated with outcome.
@en
P2093
P2860
P1476
A prospective study of treatme ...... actors associated with outcome
@en
P2093
Anna Sara S Levin
Claudia M D de Maio Carrilho
Jamile S Perozin
Juliana Gaudereto
Larissa Marques de Oliveira
Mariana Ragassi Urbano
Silvia F Costa
P2860
P2888
P356
10.1186/S12879-016-1979-Z
P577
2016-11-03T00:00:00Z